The mutation at V600E in the BRAF kinase gene appears to be an attractive molecular marker for thyroid cancer diagnosis as it has been found to be the most common genetic event in PTC, while being highly specific for this tumor (Table 2). This evidence concerns the gene BRAF and neoplasm.